WDB coco Co., Ltd. Stock

Equities

7079

JP3506010002

Business Support Services

Market Closed - Japan Exchange 02:00:00 2024-04-26 EDT 5-day change 1st Jan Change
4,515 JPY 0.00% Intraday chart for WDB coco Co., Ltd. -0.77% -2.80%

Financials

Sales 2024 * 4.6B 29.06M 39.69M Sales 2025 * 5.1B 32.22M 44.01M Capitalization 10.86B 68.6M 93.69M
Net income 2024 * 810M 5.12M 6.99M Net income 2025 * 900M 5.69M 7.77M EV / Sales 2024 * 1.83 x
Net cash position 2024 * 2.42B 15.31M 20.92M Net cash position 2025 * 2.91B 18.37M 25.08M EV / Sales 2025 * 1.56 x
P/E ratio 2024 *
13.4 x
P/E ratio 2025 *
12.1 x
Employees 471
Yield 2024 *
1.66%
Yield 2025 *
1.99%
Free-Float 25.8%
More Fundamentals * Assessed data
Dynamic Chart
1 week-0.77%
Current month-1.95%
1 month-3.94%
3 months-2.38%
6 months-13.17%
Current year-2.80%
More quotes
1 week
4 515.00
Extreme 4515
4 615.00
1 month
4 515.00
Extreme 4515
4 670.00
Current year
4 480.00
Extreme 4480
4 925.00
1 year
4 480.00
Extreme 4480
6 580.00
3 years
3 205.00
Extreme 3205
7 800.00
5 years
1 752.00
Extreme 1752
7 800.00
10 years
1 752.00
Extreme 1752
7 800.00
More quotes
Managers TitleAgeSince
President 49 14-05-31
Chief Administrative Officer 47 11-03-31
Director/Board Member 41 14-06-30
Members of the board TitleAgeSince
Director/Board Member 67 11-03-31
President 49 14-05-31
Director/Board Member 41 14-06-30
More insiders
Date Price Change Volume
24-04-26 4,515 0.00% 400
24-04-25 4,515 -0.22% 600
24-04-24 4,525 -1.20% 1,400
24-04-23 4,580 -0.11% 100
24-04-22 4,585 +0.77% 300

Delayed Quote Japan Exchange, April 26, 2024 at 02:00 am

More quotes
WDB coco CO., LTD. is a Japan-based company engaged in the contract development of pharmaceutical companies. The Company is engaged in the provision of safety information management service as an agent and support for drug development, document support service, development support service and clinical development support service. The safety information management service provides support services such as input, evaluation drafting and report drafting. The document support service provides support services from QC (quality assurance) and translation of documents and materials necessary for marketing approval to PMDA (Pharmaceuticals and Medical Devices Agency) to the creation of approval application called CTD (Common Technical Document). The development support service provides services such as survey form management, filing of survey-related documents and call center operations. The clinical development support service provides support services for clinical trial related work.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings